Back
Salesforce Vs. United States Cellular Industry Stock Comparison
Buy
57
CRM
Salesforce
Last Price:
286.81
Seasonality Move:
7.31%
Buy
71
USM
United States Cellular
Last Price:
44.04
Seasonality Move:
5.31%
Buy
57
Salesforce (CRM)
is a Buy
Is Salesforce a Buy, Sell or Hold?
- The current Salesforce [CRM] share price is $285.61. The Score for CRM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
United States Cellular (USM)
is a Buy
Is United States Cellular a Buy, Sell or Hold?
- The current United States Cellular [USM] share price is $45.10. The Score for USM is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- USM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRM Stock Price Chart
What is Salesforce's stock price today?
-
The Salesforce share price today is $285.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRM is experiencing slight selling pressure.
USM Stock Price Chart
What is United States Cellular's stock price today?
-
The United States Cellular share price today is $45.10
The current trend is moderately bullish and USM is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.92 | Sell |
| Relative Strength Index (14 RSI): | 55.76 | Buy |
| Chaikin Money Flow: | -428000 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (271.38 - 280.46) | Buy |
| Bollinger Bands (100): | (270.33 - 300.95) | Sell |
USM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.46 | Buy |
| Relative Strength Index (14 RSI): | 67.73 | Buy |
| Chaikin Money Flow: | 133355 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.95 - 42.71) | Buy |
| Bollinger Bands (100): | (34.57 - 42.69) | Buy |
CRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 280.37 | Buy |
| 20-day SMA: | 276.45 | Buy |
| 50-day SMA: | 289.22 | Sell |
| 200-day SMA: | 252.31 | Buy |
| 8-day EMA: | 281.31 | Buy |
| 20-day EMA: | 280.08 | Buy |
| 50-day EMA: | 283.43 | Buy |
| 200-day EMA: | 259 | Buy |
USM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.04 | Buy |
| 20-day SMA: | 39.26 | Buy |
| 50-day SMA: | 37.06 | Buy |
| 200-day SMA: | 40.1 | Buy |
| 8-day EMA: | 43.38 | Buy |
| 20-day EMA: | 40.49 | Buy |
| 50-day EMA: | 38.49 | Buy |
| 200-day EMA: | 36.73 | Buy |
Salesforce Earnings Growth & CRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.19 per share, an increase this year of $3.27 per share, and an increase next year of $1.60 per share.
United States Cellular Earnings Growth & USM Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.75 per share, and a decrease next year of $3.46 per share.
Salesforce Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United States Cellular Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||